Thr368

Site Information
FEYQKLytyIQsRFY SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 15425942

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	leukemia ( 1 ) , chronic myelogenous leukemia ( 1 ) , lung cancer ( 3 ) , non-small cell lung cancer ( 3 ) , ovarian cancer ( 2 ) , ovarian epithelial carcinoma ( 2 )
Relevant cell line - cell type - tissue:	K562 (erythroid) ( 1 ) , lung ( 3 ) , ovary ( 2 )

References
1	Moritz A (2011) CST Curation Set: 11306; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
2	Ren H (2010) CST Curation Set: 10133; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411 Curated Info
3	Rikova K (2007) CST Curation Set: 2269; Year: 2007; Biosample/Treatment: tissue, lung/-; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info